受强制性开放获取政策约束的文章 - Nishi Shah了解详情
无法在其他位置公开访问的文章：1 篇
Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple Myeloma.
SA Holstein, F Asimakopoulos, AK Azab, G Bianchi, M Bhutani, LA Crews, ...
Transplantation and Cellular Therapy 28 (8), 446-454, 2022
强制性开放获取政策： US National Institutes of Health, Cancer Research UK
可在其他位置公开访问的文章：21 篇
Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy
R Shouval, A Alarcon Tomas, JA Fein, JR Flynn, E Markovits, S Mayer, ...
Journal of clinical oncology 40 (4), 369-381, 2022
强制性开放获取政策： US National Institutes of Health
Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes
A Verma, RNVS Suragani, S Aluri, N Shah, TD Bhagat, MJ Alexander, ...
The Journal of Clinical Investigation 130 (2), 582-589, 2020
强制性开放获取政策： US National Institutes of Health
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma
A Alarcon Tomas, JA Fein, S Fried, JR Flynn, SM Devlin, WB Fingrut, ...
Leukemia 37 (1), 154-163, 2023
强制性开放获取政策： US National Institutes of Health
Activation of targetable inflammatory immune signaling is seen in myelodysplastic syndromes with SF3B1 mutations
GS Choudhary, A Pellagatti, B Agianian, MA Smith, TD Bhagat, ...
Elife 11, e78136, 2022
强制性开放获取政策： US National Institutes of Health, Blood Cancer UK, National Institute for …
Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation
AK Nooka, HR Johnson, JL Kaufman, CR Flowers, A Langston, C Steuer, ...
Biology of Blood and Marrow Transplantation 20 (6), 852-857, 2014
强制性开放获取政策： US National Institutes of Health
Epidemiology and survival trend of adult T‐cell leukemia/lymphoma in the United States
UA Shah, N Shah, B Qiao, A Acuna‐Villaorduna, K Pradhan, ...
Cancer 126 (3), 567-574, 2020
强制性开放获取政策： US National Institutes of Health
Patterns of leukocyte recovery predict infectious complications after CD19 CAR-T cell therapy in a real-world setting
A Thakkar, Z Cui, SZ Peeke, N Shah, K Pradhan, A Lombardo, F Khatun, ...
Stem cell investigation 8, 2021
强制性开放获取政策： US National Institutes of Health
Hematopoietic cell transplantation is feasible in patients with prior COVID-19 infection
N Shah, PB Dahi, DM Ponce, CS Sauter, BC Shaffer, DJ Chung, ...
Transplantation and Cellular Therapy 28 (1), 55. e1-55. e5, 2022
强制性开放获取政策： US National Institutes of Health
Dermatology evaluation for cutaneous immune-related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition
TV Jacoby, N Shah, MS Asdourian, LL Thompson, TS Otto, NR LeBoeuf, ...
Journal of the American Academy of Dermatology 88 (3), 711-714, 2023
强制性开放获取政策： US National Institutes of Health
Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1–Associated Adult T Cell Lymphoma–Leukemia in the United States: Experience …
DA Herrera, N Kornblum, A Acuna-Villaorduna, RA Sica, U Shah, M Butler, ...
Biology of Blood and Marrow Transplantation 25 (6), e199-e203, 2019
强制性开放获取政策： US National Institutes of Health
Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma
MS Asdourian, TS Otto, TV Jacoby, N Shah, LL Thompson, SM Blum, ...
Journal of the American Academy of Dermatology 87 (5), 1147-1149, 2022
强制性开放获取政策： US National Institutes of Health
Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma
MR Stephens, MS Asdourian, TV Jacoby, N Shah, LL Thompson, T Otto, ...
Journal of the American Academy of Dermatology 89 (1), 140-142, 2023
强制性开放获取政策： US National Institutes of Health
Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade
MS Asdourian, N Shah, TV Jacoby, YR Semenov, T Otto, LL Thompson, ...
Journal of the American Academy of Dermatology 88 (2), 485-487, 2023
强制性开放获取政策： US National Institutes of Health
Evaluating patterns of co-occurrence between cutaneous and noncutaneous immune-related adverse events after immune checkpoint inhibitor therapy
MS Asdourian, N Shah, TV Jacoby, LL Thompson, T Otto, YR Semenov, ...
Journal of the American Academy of Dermatology 88 (1), 246-249, 2023
强制性开放获取政策： US National Institutes of Health
Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma
K Nath, AA Tomas, J Flynn, JA Fein, A Alperovich, T Anagnostou, ...
Transplantation and cellular therapy 28 (11), 751. e1-751. e7, 2022
强制性开放获取政策： US National Institutes of Health
High prevalence of pulmonary findings in computed tomographies of HTLV-1-infected patients with and without adult-T cell leukemia/lymphoma–implications for staging
A Acuna-Villaorduna, J Gonzalez-Lugo, BH Ye, DAA Herrera, RA Sica, ...
Leukemia & lymphoma, 2019
强制性开放获取政策： US National Institutes of Health
Global longitudinal strain is associated with mortality in patients with multiple myeloma
Z Cui, F Castagna, W Hanif, SJ Apple, L Zhang, JM Tauras, ...
Journal of Clinical Medicine 12 (7), 2595, 2023
强制性开放获取政策： US National Institutes of Health
Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy
MS Asdourian, TV Jacoby, N Shah, T Otto, LL Thompson, EC Dee, ...
Journal of the American Academy of Dermatology 88 (6), 1368-1370, 2023
强制性开放获取政策： US National Institutes of Health
Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: a …
MS Asdourian, TV Jacoby, N Shah, LL Thompson, T Otto, YR Semenov, ...
Journal of the American Academy of Dermatology 88 (2), 474, 2022
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定